Brendan M. O'Malley

Brendan M. O'Malley, listed as board member, appears in our data through filings on Abeona Therapeutics Inc. shares, published by SEC (Form 4). In total, 35 filings cover trades dated from 20 September 2021 to 29 September 2026.

Both buying and selling appear: 4 purchases worth €83k, against 14 sales worth €467k. Netting one side against the other leaves €384k of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 17 share grants. Since January 2026: no purchases and 5 sales on the market.

Half of the purchases are above €22k and half below. Of 4 purchases, 3 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.

On 29 September 2026 came the latest disclosure, an open-market sale for €30k in Abeona Therapeutics Inc. The latest purchase dates back some time: it was published 910 days ago, on 26 April 2024. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.